Staying on top of things right from the start: The obsessive-compulsive disorder of regulatory T cells

Journal of the American Society of Nephrology

Volumn 21, Issue 1, 2010, Pages 6-7

  Steinmetz, Oliver M ^a,b   Turner, Jan Eric ^a   Panzer, Ulf ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7;

EDITORIAL; GLOMERULONEPHRITIS; HUMAN; IMMUNE COMPLEX NEPHRITIS; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 75149158372     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009111140     Document Type: Editorial

References (14)

1. Eller K, Weber T, Pruenster M, Wolf AM, Mayer G, Rosenkranz AR, Rot A: CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J Am Soc Nephrol 21: 42-52, 2010
2. Forster R, Davalos-Misslitz AC, Rot A: CCR7 and its ligands: Balancing immunity and tolerance. Nat Rev Immunol 8: 362-371, 2008
3. Debes GF, Arnold CN, Young AJ, Krautwald S, Lipp M, Hay JB, Butcher EC: Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol 6: 889-894, 2005
4. Bromley SK, Thomas SY, Luster AD: Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6: 895-901, 2005
5. Davalos-Misslitz AC, Rieckenberg J, Willenzon S, Worbs T, Kremmer E, Bernhardt G, Forster R: Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur J Immunol 37: 613-622, 2007
6. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A: CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 204: 735-745, 2007
7. Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR: CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16: 1360-1370, 2005
8. Vignali DA, Collison LW, Workman CJ: How regulatory T cells work. Nat Rev Immunol 8: 523-532, 2008
9. Feuerer M, Hill JA, Mathis D, Benoist C: Foxp3+ regulatory T cells: Differentiation, specification, subphenotypes. Nat Immunol 10: 689-695, 2009
10. Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT, Corcoran L, Treuting P, Klein U, Rudensky AY: Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458: 351-356, 2009
11. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY: CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science October 1, 2009 [epub ahead of print]
12. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ: The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10: 595-602, 2009
13. Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, Dankof A, Krenn V, Schon MP, Scheffold A, Lowe JB, Hamann A, Syrbe U, Huehn J: Migration matters: Regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104, 2005
14. Dudda JC, Perdue N, Bachtanian E, Campbell DJ: Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med 205: 1559-1565, 2008